LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Digital Pathology Technology Set to Transform Medical Diagnosis

By LabMedica International staff writers
Posted on 03 Aug 2023
Print article
Image: The digital pathology scanner significantly improves tests in terms of cost, quality and speed (Photo courtesy of SNP)
Image: The digital pathology scanner significantly improves tests in terms of cost, quality and speed (Photo courtesy of SNP)

Pathologists have historically encountered significant challenges in acquiring sharp, in-focus images without manual intervention. Given that digital pathology images are often thousands of times larger than regular digital photos, automating microscopy for diagnosis from tissue, blood, and other specimen types was considered impossible. However, after a decade of rigorous research by a team of scientists, a transformative breakthrough in medical diagnosis is set to enhance the speed and accuracy of pathology results.

Queensland University of Technology (QUT, Brisbane, Australia) and Sullivan Nicolaides Pathology (SNP, Queensland, Australia) have pioneered an automated microscope scanning and analysis system that has undergone rigorous testing and is now implemented and accredited, ready for global deployment. The system has been shown to significantly improve testing in terms of cost-efficiency, quality, and speed. The cutting-edge digital pathology technology is capable of processing thousands of tests daily and has received accreditation from the National Association of Testing Authorities (NATA).

The system has been shown to enhance the productivity of pathologists and scientists by a factor of 10 or more. It also offers the benefit of seeking second opinions through telepathology and significantly improves record-keeping and access to historical records as there is no need to archive glass slides for years. The system is poised to revolutionize various aspects of healthcare and is already being used by SNP laboratories to enhance diagnostic speed and accuracy.

“Our scientists now use a digitized image often with associated AI instead of being tied to a microscope for many hours,” said SNP Chief Executive Officer Dr. Michael Harrison. “This is the most significant change in the performance of morphological tests for decades.”

“Our active scanner knows what it is scanning and where it should scan, using image analysis and artificial intelligence,” added UQ Professor of AI Brian Lovell. “This greatly increases image quality and reduces file size.”

Related Links:
QUT  
SNP 

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.